**
In a recent address, Professor Sir Chris Whitty, England’s Chief Medical Officer, expressed concerns regarding the increasing reliance on weight-loss medications to combat the nation’s obesity crisis. While acknowledging the benefits of drugs like Wegovy and Mounjaro for a select group of individuals, Whitty warned that depending on these treatments as a primary solution would signify a failure in both societal and medical approaches to health.
The Current Landscape of Obesity in the UK
Approximately two-thirds of adults in the UK are classified as overweight or obese, a statistic that has seen drastic escalation since the early 1990s. At that time, the obesity rates in the UK and France were comparable. However, in the years that followed, France has managed to maintain stable obesity levels, while the UK has witnessed a significant rise. Whitty emphasized the need for a paradigm shift in how society addresses this pressing health issue.
The Role of Weight-Loss Medications
Weight-loss medications work by mimicking hormones that signal satiety after meals, thus helping to reduce appetite. Currently, the NHS provides these drugs through specialised weight management services, primarily for those in dire need. However, a burgeoning private market has emerged, with many individuals spending substantial amounts monthly for access to these treatments. In the past year alone, around 1.6 million individuals in the UK have experimented with weight-loss drugs, prompting concerns about the potential for widespread dependency.

Whitty cautioned that if a large segment of the population were to rely on these medications, it would represent a significant failure of public health initiatives. He questioned whether society should simply abandon proactive health strategies in favour of pharmacological solutions.
A Call for Healthy Eating Habits
During his speech at the Medical Journalists’ Association annual lecture, Whitty highlighted the importance of promoting healthier eating habits as a proactive measure against obesity. He noted that the aggressive marketing of unhealthy foods, particularly towards children, exacerbates the issue, leaving the healthcare system to deal with the long-term consequences.
Drawing comparisons between food environments in the UK and France, he remarked on the stark differences in availability and accessibility of healthy options. In many UK towns, such as Wigan and Blackpool, junk food is omnipresent, creating barriers to making healthier choices.
Whitty argued that the responsibility lies with society to make healthier food options both appealing and affordable. He cited the French culinary culture as a model, suggesting that it is entirely feasible to reframe dietary habits without sacrificing enjoyment or taste.
The Path Forward
Whitty’s assertions serve as a rallying cry for a collective reevaluation of how the UK addresses obesity. He insists that while weight-loss drugs may hold transformative potential for a minority, they should not overshadow the need for systemic changes in food culture and public health policy.

As the nation grapples with the implications of rising obesity rates, the focus must shift toward fostering environments that encourage healthy eating and sustainable lifestyle choices.
Why it Matters
The conversation surrounding obesity is not merely about individual choices; it encompasses broader societal responsibilities. As public health officials like Sir Chris Whitty advocate for a shift in focus from medication to prevention, the call to action is clear: a healthier society begins with nurturing environments that support nutritious eating and physical well-being. By learning from successful models abroad and prioritising public health initiatives, the UK can aspire to create a future where obesity is no longer a pervasive challenge, but a manageable concern through informed choices and communal support.